Welcome to PamGene

PamGene is a biomarker company, focusing on new opportunities in the arena of personalized medicine (pre-clinical, translational and clinical).


Most of PamGene’s projects are in oncology and many of these involve medicines that inhibit or modulate cellular kinases and kinase pathways. Our technology is applied for biomarker research in several other diseases and fields of expertise such as the central nervous system, the cardiovascular area, immunology and obesity. PamGene provides access to its technology through offering of Services. In addition, PamGene sells microarray equipment, PamStation, and PamChip microarray products. 

Listen to the experts
who use our technology
Our oncology applications
to study kinase inhibitors
Our research applications
for mechanistic insights

Prof. Dr. Anne Hansen Ree, MD, Oslo Norway.

“Multiplex kinase activity profiling using PamGene’s kinase arrays suggested we can identify functional biomarkers predictive of tumour response to preoperative CRT in patients with Locally Advanced Rectal Cancer.”

Read more

Our technology is able to measure kinase activity in small biopsies from patients. Since the readout is done kinetically it even allows you to determine sensitivity to kinase inhibitors prior to treatment.This makes personalized medicine a real possibility.

Read more

Are you interested in identifying new signal transduction pathways in the models you are investigating? PamGene's technology allows you to measure activities rather than presence of kinases in your models using its peptide arrays and fully automated workstations.

Read more
ISO Accreditation for the Diagnostic Assay Services Lab
New Career Opportunities at PamGene
PamGene's NHR platform in major EDCMET Consortium
At ASCO 2018: Predictive biomarkers for immunotherapy in Mel...
AACR 2018 follow-up